outsourcing

Market Access

Sustaining the mature product portfolio through strategic ou...

Globalisation and the growth of emerging markets has created new opportunities to expand the reach for the mature portfolio.

News

Nick Green, president and CEO of Avid Bioservices

Avid Bioservices to go private in $1.1bn private equity deal

Anglo-US contract development and manufacturing organisation (CDMO) Avid Bioservices has agreed a deal to be acquired by private equity firms GHO Capital Partners and Ampersand Capital Part

News

BIOSECURE Act clears House vote

The US House of Representatives comprehensively voted in favour of the BIOSECURE Act, which will prohibit businesses in the US from contracting with various Chinese firms on national securi

News

Agilent builds its CDMO arm with $925m Biovectra buy

Agilent has boosted its contract development and manufacturing organisation (CDMO) capacity with a $925 million deal to buy Biovectra, a Canadian provider of fill-and-finish services and ac

News

Aerial vew of Discovery Park in Sandwich, Kent

Chinese firm throws lifeline to Pfizer UK plant workers

China’s Asymchem Laboratories has agreed to take over the operation of a Pfizer UK manufacturing facility in Sandwich, Kent, safeguarding dozens of jobs.

News

First cGMP Cell Shuttle & Cellares co-founders Omar Kurdi (left) and Fabian Gerlinghaus (right)

BMS preps for CAR-T growth with $380m Cellares deal

Bristol-Myers Squibb has shored up manufacturing of its CAR-T therapies, tapping into capacity at contract manufacturer Cellares that will be used to supply patients in th

Sustaining the mature product portfolio through strategic ou...

Avid Bioservices to go private in $1.1bn private equity deal

BIOSECURE Act clears House vote

Agilent builds its CDMO arm with $925m Biovectra buy

Chinese firm throws lifeline to Pfizer UK plant workers

BMS preps for CAR-T growth with $380m Cellares deal

Ambros' $125m for pain disorder drug, and other financings

How to meet your physicians where they are online

outsourcing

Editor's Picks